Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy

We had previously reported that transduction of the channelrhodopsin-2 (ChR2) gene into retinal ganglion cells restores visual function in genetically blind, dystrophic Royal College of Surgeons (RCS) rats. In this study, we attempted to reveal the safety and influence of exogenous ChR2 gene expression. Adeno-associated virus (AAV) type 2 encoding ChR2 fused to Venus (rAAV-ChR2V) was administered by intra-vitreous injection to dystrophic RCS rats. However, rAAV-ChR2 gene expression was detected in non-target organs (intestine, lung and heart) in some cases. ChR2 function, monitored by recording visually evoked potentials, was stable across the observation period (64 weeks). No change in retinal histology and no inflammatory marker of leucocyte adhesion in the retinal vasculature were observed. Although antibodies to rAAV (0.01–12.21 μg ml−1) and ChR2 (0–4.77 μg ml−1) were detected, their levels were too low for rejection. T-lymphocyte analysis revealed recognition by T cells and a transient inflammation-like immune reaction only until 1 month after the rAAV-ChR2V injection. In conclusion, ChR2, which originates from Chlamydomonas reinhardtii, can be expressed without immunologically harmful reactions in vivo. These findings will help studies of ChR2 gene transfer to restore vision in progressed retinitis pigmentosa.

[1]  X. Li,et al.  Prenatal exposure to lipopolysaccharide results in cognitive deficits in age-increasing offspring rats , 2010, Neuroscience.

[2]  C. Zoccali,et al.  [Clinical trials (Part I)]. , 2010, Giornale Italiano di Nefrologia.

[3]  Eriko Sugano,et al.  Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. , 2010, Experimental eye research.

[4]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[5]  James M. Wilson,et al.  A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  E. Bamberg,et al.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Eleftherios S. Papathanasiou,et al.  Visual cortical plasticity following unilateral sensorimotor cortical lesions in the neonatal rat , 2006, Experimental Neurology.

[8]  C. Distler,et al.  Alterations of Müller (glial) cells in dystrophic retinae of RCS rats , 1995, Journal of neurocytology.

[9]  S. Kügler,et al.  Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. , 2003, Virology.

[10]  Douglas S Kim,et al.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration , 2008, Nature Neuroscience.

[11]  M. Atkinson,et al.  Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity , 2004, Gene Therapy.

[12]  R. Jope,et al.  Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain , 2009, Journal of Neuroinflammation.

[13]  Sung-Sam Lim,et al.  T lymphocyte subpopulations and interleukin-2, interferon-gamma, and interleukin-4 in rat pulpitis experimentally induced by specific bacteria. , 2002, Journal of endodontics.

[14]  A. O’Garra,et al.  Regulatory T cells and mechanisms of immune system control , 2004, Nature Medicine.

[15]  小泉 閑.  Contribution of TNF-α to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo , 2003 .

[16]  A. Negi,et al.  Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. , 2002, Experimental eye research.

[17]  L. Wade,et al.  A quantitative study of intramembrane changes during cell junctional breakdown in the dystrophic rat retinal pigment epithelium. , 1984, Experimental cell research.

[18]  E. Sugano,et al.  Establishment of effective methods for transducing genes into iris pigment epithelial cells by using adeno-associated virus type 2. , 2005, Investigative ophthalmology & visual science.

[19]  C. Kaltschmidt,et al.  NF-kappa B: a crucial transcription factor for glial and neuronal cell function. , 1997, Trends in neurosciences.

[20]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[21]  Y. Fujii,et al.  The effects of certain H1-antagonists on visual evoked potential in rats , 2003, Brain Research Bulletin.

[22]  B. Kirchhof,et al.  Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. , 2003, Investigative ophthalmology & visual science.

[23]  H. Neumann,et al.  Constitutive NF-kappa B activity in neurons , 1994, Molecular and cellular biology.

[24]  I. Bernard,et al.  A dominant role for the thymus and MHC genes in determining the peripheral CD4/CD8 T cell ratio in the rat. , 1999, Journal of immunology.

[25]  Hai-dong Xu,et al.  Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration , 2009, Experimental Neurology.

[26]  Toru Ishizuka,et al.  Visual Properties of Transgenic Rats Harboring the Channelrhodopsin-2 Gene Regulated by the Thy-1.2 Promoter , 2009, PloS one.

[27]  C. Kaltschmidt,et al.  NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.

[28]  U. Griesenbach.  Progress and Prospects: Gene Therapy Clinical Trials (Part 2) , 2007, Gene Therapy.

[29]  E. Alton.  Progress and Prospects: Gene Therapy Clinical Trials (Part 1) , 2007, Gene Therapy.

[30]  R. Herzog,et al.  Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. , 2009, Blood.

[31]  A. Dizhoor,et al.  Ectopic Expression of a Microbial-Type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration , 2006, Neuron.

[32]  Theresa A. Storm,et al.  Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo , 2001, Journal of Virology.

[33]  James M. Wilson,et al.  Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. , 2001, Human gene therapy.

[34]  Toru Ishizuka,et al.  Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. , 2007, Investigative ophthalmology & visual science.

[35]  H. Blum,et al.  T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection , 2005, Journal of Virology.

[36]  T. Ishizuka,et al.  Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae light-gated channels , 2006, Neuroscience Research.

[37]  S. Sakaguchi.  Regulatory T cells , 2006, Springer Seminars in Immunopathology.

[38]  P. Brust,et al.  Potassium as a signal for both proliferation and differentiation of rabbit retinal (Müller) glia growing in cell culture. , 1989, Cellular signalling.

[39]  C. Piccirillo,et al.  Development and function of naturally occurring CD4+CD25+ regulatory T cells , 2006, Journal of leukocyte biology.

[40]  S. Dunnett,et al.  HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity , 2004, Brain Research.

[41]  W. C. Hall,et al.  High-speed mapping of synaptic connectivity using photostimulation in Channelrhodopsin-2 transgenic mice , 2007, Proceedings of the National Academy of Sciences.

[42]  C. Johnson.  Progress and Prospects , 1991 .

[43]  N. Sharpless,et al.  Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  K. Tsubota,et al.  Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. , 2006, Investigative ophthalmology & visual science.

[45]  E. Simpson.  A historical perspective on immunological privilege , 2006, Immunological reviews.

[46]  T. Fujikado,et al.  Optimal parameters of transcorneal electrical stimulation (TES) to be neuroprotective of axotomized RGCs in adult rats. , 2010, Experimental eye research.

[47]  A. Sadun,et al.  Nuclear factor-κB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats , 2006, Brain Research.

[48]  R. Caldwell,et al.  Intramembrane changes in retinal pigment epithelial cell junctions of the dystrophic rat retina. , 1982, Investigative ophthalmology & visual science.

[49]  R. Caldwell,et al.  Retinal pigment epithelial cells from dystrophic rats form normal tight junctions in vitro. , 1997, Investigative ophthalmology & visual science.

[50]  A. Milam,et al.  Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. , 1997, Archives of ophthalmology.

[51]  R. Caldwell,et al.  Permeability of retinal pigment epithelial cell junctions in the dystrophic rat retina. , 1983, Experimental Eye Research.